C12Y 111/01009
Glutathione peroxidase
Official title: Glutathione peroxidase (1.11.1.9)
C12Y111/01009 (Glutathione peroxidase) appears on 11 US grants and 32 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 32
- Assignees
- 26
- Inventors
- 86
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 2 |
| 2003 | 1 | 2 |
| 2004 | 0 | 4 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 2 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thrombolytic and neuro/vasculoprotective nanoconjugates9 Sep 2025US 12,409,147 B2The Cleveland Clinic Foundation
- Selenium-containing nano HOF, antioxidant nanozyme, preparation method and application thereof5 Aug 2025US 12,378,187 B1Hangzhou Normal University
- Recombinant yeast strain for producing nervonic acids and application thereof14 Mar 2023US 11,603,545 B2Qindao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences
- Method for treating damage induced by sleep deprivation13 Sep 2022US 11,439,675 B2President and Fellows of Harvard College
- Enzymatic treatment of retinitis pigmentosis4 Nov 2008US 7,445,777 B2
- Ovarian tumor deubiquitinase oxidation and uses thereof29 Jan 2026US 2026/0027190 A1University of Vermont and State Agricultural College
- Thrombolytic and neuro/vasculoprotective nanoconjugates8 Jan 2026US 2026/0007614 A1The Cleveland Clinic Foundation
- Application of PRDX5 and GPX4 Genes in Preparation of Drugs for Castration-resistant Prostate Cancer27 Feb 2025US 2025/0066794 A1Jiangnan University
- Artificial enzyme-bacteria system and uses thereof9 Jan 2025US 2025/0009902 A1
- Therapy for programmed cell death in a subject transplanted with a donor liver carrying the pnpla3 rs738409:g variant2 Jan 2025US 2025/0001009 A1Kyushu University, National University Corporation
Most cited
By later US patents
- Human glutathione peroxidase-651US 6,231,853 B1Incyte Pharmaceuticals, Inc. · 2001
- Protection against rhabdomyolysis-induced nephrotoxicity32US 5,091,180 AThe Administrators of the Tulane Educational Fund · 1992
- Transgenic animals and related aspects5US 5,859,308 AUniversity of Medicine & Denistry of New Jersey · 1999
- Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease5US 6,613,519 B1Rappaport Family Institute for Reseach in the Medical Sciences · 2003
- Adenovirus comprising a gene coding for glutathione peroxidase1US 7,241,591 B2Aventis Pharma S. A. · 2007